Trinity Biotech (TRIB) has obtained an additional $4M in debt financing from its primary lender, Perceptive Advisors. The additional liquidity ...

Following positive pre-pivotal trial results, Trinity Biotech is concentrating on its CGM technology while pursuing operational efficiencies to strengthen its financial position. The press release ...

The additional liquidity will support both the continued development of Trinity Biotech’s innovative continuous glucose monitoring (CGM) technology and the Company Trinity Biotech’s patented ...

In other recent news, Trinity Biotech has made significant strides with its continuous glucose monitoring (CGM) system, reporting a 35% improvement in Mean Absolute Relative Difference (MARD ...

In other recent news, Trinity Biotech has made significant strides with its continuous glucose monitoring (CGM) system, reporting a 35% improvement in Mean Absolute Relative Difference (MARD) and over ...

Trinity Biotech notes the additional liquidity will support both the continued development of their innovative continuous glucose monitoring (CGM) technology and the Company’s comprehensive ...

Research analysts at StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a report released on Wednesday. The firm set a “hold” rating on the stock. Trinity ...

Keep a constant eye on your blood sugar levels and sync your results to a phone or a smart watch with a top-quality CGM. Want to track your glucose levels without the hassle of finger pricks?

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...